The regulation of microglia by aging and autophagy in multiple sclerosis

Area of Science:

• Neuroimmunology
• Cellular Biology
• Neurodegenerative Diseases

Background:

• Multiple sclerosis (MS) is an inflammatory neurological disease with irreversible disability, strongly influenced by age.
• Aging microglia exhibit altered gene expression, resembling disease-associated microglia (DAM), with reduced phagocytosis and increased inflammation.
• Impaired myelin clearance by aged microglia and decreased autophagy activity contribute to MS pathology.

Purpose of the Study:

• To review the roles of autophagy and aging in the context of multiple sclerosis.
• To examine the impact of autophagy and aging on microglial activation and function in MS.
• To identify molecular mechanisms linking autophagy, aging, and microglial dysfunction in MS.

Main Methods:

• Literature review synthesizing evidence on autophagy, aging, and microglia in MS.
• Analysis of gene expression signatures in aging microglia and their overlap with MS and DAM phenotypes.
• Examination of molecular pathways governing microglial phagocytosis and inflammatory responses in aging.

Main Results:

• Aging is associated with decreased microglial autophagy and phagocytic capacity.
• Microglial gene expression in aging overlaps with MS and DAM, characterized by reduced clearance and heightened inflammation.
• Impaired autophagy in aging microglia exacerbates chronic inflammation and disease progression in MS.

Conclusions:

• Reduced autophagy in aging microglia impairs phagocytosis and promotes inflammation, contributing to MS progression.
• Targeting microglial autophagy presents a potential therapeutic avenue for managing multiple sclerosis.
• Understanding the interplay between aging, autophagy, and microglial function is crucial for developing novel MS therapies.